Progress in cardiovascular diseases · 2024
Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Belmonte Marta, Foà Alberto, Paolisso Pasquale, Bergamaschi Luca, Gallinoro Emanuele, Polimeni Alberto, Scarsini Roberto, Muscoli Saverio, Amicone Sara, De Vita Antonio, Villano Angelo, Angeli Francesco, Armillotta Matteo, Sucato Vincenzo, Tremamunno Saverio, Morrone Doralisa, Indolfi Ciro, Filardi Pasquale Perrone, Ribichini Flavio, Lanza Gaetano Antonio, Chieffo Alaide, Barbato Emanuele, Pizzi Carmine, Coronary Physiopathology and Microcirculation Working Group of the Italian Society of Cardiology (SIC)
Аннотация
The prevalence of coronary microvascular dysfunction (CMD) beyond the spectrum of chronic coronary syndromes (CCS) is non-negligible, pertaining to pathophysiological and therapeutical implications. Thanks to the availability of accurate and safe non-invasive technique, CMD can be identified as a key player in heart failure, cardiomyopathies, Takotsubo syndrome, aortic stenosis. While CMD is widely recognized as a cause of myocardial ischemia leading to a worse prognosis even in the absence of obstructive coronary artery disease, the characterization of CMD patterns beyond CCS might provide valuable insights on the underlying disease progression, being potentially a "red flag" of adverse cardiac remodeling and a major determinant of response to therapy and outcomes. In this review, we aimed to provide an overview of the latest evidence on the prevalence, mechanistic and prognostic implications of CMD beyond the spectrum of CCS (i.e. heart failure, cardiomyopathies, Takotsubo syndrome, aortic stenosis).